Low-density lipoprotein apheresis and changes in plasma components

Therapeutic Apheresis

Volumn 5, Issue 4, 2001, Pages 232-238

  Kojima, Shunichi ^a  

^a SHIZUOKA MEDICAL CENTER   (Japan)

Author keywords

Amyloidosis; Bradykinin; Hypercholesterolemia; Lipoprotein (a); Low density lipoprotein apheresis

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID P COMPONENT; APOLIPOPROTEIN B; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BRADYKININ; DEXTRAN SULFATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRONECTIN; HIGH MOLECULAR WEIGHT KININOGEN; LOW DENSITY LIPOPROTEIN; PREKALLIKREIN; SCATTER FACTOR; VON WILLEBRAND FACTOR;

ADSORPTION; APHERESIS; ARTICLE; BLOOD CLOTTING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPHILICITY; PRIORITY JOURNAL;

ADSORPTION; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD COAGULATION; BRADYKININ; DEXTRAN SULFATE; HUMANS; LIPOPROTEINS, LDL; PLASMA VOLUME; PLASMAPHERESIS;

EID: 0035152446     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2001.00344.x     Document Type: Article

References (29)

1. Assessment of long-term plasma exchange for familial hypercholesterolemia
2. Double filtration plasmapheresis
3. Application of specific extracorporeal removal of low-density lipoprotein in familial hypercholesterolemia
4. Selective removal of low density lipoproteins (LDL) by precipitation at low pH: First clinical application of the HELP system
5. Selective removal of low density lipoproteins by plasmapheresis in familial hypercholesterolemia
6. Lipid apheresis by hemoperfusion: In vitro efficacy and ex vivo bio-compatibility of a new low-density lipoprotein adsorber compatible with human whole blood
7. Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: A multicenter study
8. Evaluation of cholesterol and lipoprotein (a) removal by low density lipoprotein apheresis
9. Changes in coagulation factors by passage through a dextran sulfate column during low-density lipoprotein apheresis
10. Changes in serum amyloid proteins during LDL apheresis
11. Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis
12. Lp(a) lipoprotein and pre-betalipoprotein in patients with coronary heart disease
13. Lipoprotein(a) in ischemic cerebrovascular disease: A new assessment of risk for stroke
14. Effect of nafamostat mesilate on bradykinin generation during low-density lipoprotein apheresis with dextran sulphate column
15. Pharmacological studies of FUT-175, nafamostat mesilate-inhibition of protease activity in in vitro and in vivo experiments
16. Anaphylactoid reactions, LDL apheresis with dextran sulfate, and ACE inhibitors
17. Effects of losartan on low-density lipoprotein apheresis
18. The requirement of endothelial cells in the relaxation of the arteries by acetylcholine and some other vasodilators
19. Release of a prostaglandin E-like substance from canine kidney by bradykinin
20. Vascular endothelial cells synthesize nitric oxide from L-arginine
21. Changes in plasma levels of nitric oxide derivative during low-density lipoprotein apheresis
22. Changes in bradykinin and prostaglandin plasma levels during dextran-sulfate low-densitylipoprotein apheresis
23. Familial hypercholesterolemia regression study: A randomized trial of low-density-lipoprotein apheresis
24. Low-density-lipoprotein apheresis
25. Fat-soluble vitamins
26. Changes in serum amyloid proteins during LDL apheresis
27. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial motility and growth
28. Acute changes in plasma levels of hepatocyte growth factor during LDL apheresis
29. Changes in coagulation factors during cascade filtration with EVAL-5A filter